Cargando…

Omalizumab in chronic spontaneous urticaria (CSU): experience in three cases

Detalles Bibliográficos
Autores principales:	Valle, Solange Oliveira Rodrigues, Levy, Soloni Afra Pires, Dortas, Sérgio Duarte, Filho, José Elabras, Fernandes, Renata Silva, França, Alfeu Tavares, Monteiro De Castro, Cynthia S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Allergy Organization 2015
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406720/ http://dx.doi.org/10.1186/1939-4551-8-S1-A155

Ejemplares similares

Analysis of the prevalence of subtypes of angioedema without urticaria in a reference center in Rio de Janeiro – Brazil
por: Fernandes, Renata Silva, et al.
Publicado: (2015)

Omalizumab as add-on therapy in patients with asthma and allergic bronchopulmonary aspergillosis
por: da Cunha, Fernanda Sales, et al.
Publicado: (2018)

Impact of chronic urticaria on the quality of life of patients followed up at a university hospital
por: Dias, Gabriela Andrade Coelho, et al.
Publicado: (2016)

Short-term prophylaxis (STP) with plasma derived human C1 inhibitor concentrate (pdhC1-INH) in two pregnant women with hereditary angioedema (HAE): an experience in Rio de Janeiro – Brazil
por: Valle, Solange Oliveira Rodrigues, et al.
Publicado: (2015)

Obesity: an asthma aggravating factor?
por: Filho, José Elabras, et al.
Publicado: (2015)

Chronic urticaria: profile from a reference center()
por: de Souza, Ana Carolina Miranda Carvalho Ferreira Fernandes, et al.
Publicado: (2022)

Drug rash induced by levothyroxine and oral desensitization
por: Dortas, Sérgio Duarte, et al.
Publicado: (2015)

Staphylococcal superantigen-specific IgE antibodies and its correlation with asthma severity
por: Filho, José Elabras, et al.
Publicado: (2015)

Autoimmune progesterone dermatitis (AIPD) triggered by intrauterine device (IUD): case report
por: Bard De Carvalho, Ana Luiza Ribeiro, et al.
Publicado: (2015)

Clinical Remission of Chronic Spontaneous Urticaria (CSU): A Targeted Literature Review
por: Balp, Maria-Magdalena, et al.
Publicado: (2021)

Thyroid Autoimmunity in CSU: A Potential Marker of Omalizumab Response?
por: Asero, Riccardo, et al.
Publicado: (2023)

The burden of chronic spontaneous urticaria is substantial: Real‐world evidence from ASSURE‐CSU
por: Maurer, M., et al.
Publicado: (2017)

Increased serum free IgE levels in patients with chronic spontaneous urticaria (CSU)()
por: Jang, Jae-Hyuk, et al.
Publicado: (2022)

Staphylococcal superantigen-specific IgE antibodies: degree of sensitization and association with severity of asthma
por: Elabras, José, et al.
Publicado: (2016)

Systemic nickel allergy syndrome
por: Da Mata Perez, Luciana, et al.
Publicado: (2015)

OMALIZUMAB IN TREATMENT-RESISTANT CHRONIC SPONTANEOUS URTICARIA
por: Godse, Kiran V
Publicado: (2011)

Profile of omalizumab in the treatment of chronic spontaneous urticaria
por: Labrador-Horrillo, Moises, et al.
Publicado: (2015)

ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria
por: Weller, Karsten, et al.
Publicado: (2015)

Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: Analyses from ASSURE‐CSU
por: Sussman, G., et al.
Publicado: (2018)

Case Report: Omalizumab for Chronic Spontaneous Urticaria in Pregnancy
por: Liao, Shuang-Lu, et al.
Publicado: (2021)

Omalizumab's efficacy and safety against chronic spontaneous urticaria
por: Özdemir, Öner
Publicado: (2023)

Management of chronic spontaneous urticaria (CSU): a treat to target approach using a patient reported outcome
por: Lima, Hermenio, et al.
Publicado: (2017)

Effects of Vaccination against COVID-19 in Chronic Spontaneous and Inducible Urticaria (CSU/CIU) Patients: A Monocentric Study
por: Grieco, Teresa, et al.
Publicado: (2022)

Type I and type IIb autoimmune chronic spontaneous urticaria: Using common clinical tools for endotyping patients with CSU
por: Sella, Juliana A., et al.
Publicado: (2023)

Omalizumab is effective in the treatment of difficult-to-treat chronic spontaneous urticaria
por: Forgie, Jennifer, et al.
Publicado: (2014)

Use of biologics in chronic spontaneous urticaria – beyond omalizumab therapy?
por: Metz, Martin, et al.
Publicado: (2021)

Sex differences in the efficacy of omalizumab in the treatment of chronic spontaneous urticaria
por: Sirufo, Maria Maddalena, et al.
Publicado: (2022)

Omalizumab treatment for chronic spontaneous urticaria: data from Turkey
por: Kara, Rabia Oztas, et al.
Publicado: (2022)

Cost‐effectiveness of personalized omalizumab dosing for chronic spontaneous urticaria
por: Denman, Sarah, et al.
Publicado: (2022)

Omalizumab treatment and outcomes in Chinese patients with chronic spontaneous urticaria, chronic inducible urticaria, or both
por: Chen, Yudi, et al.
Publicado: (2021)

O10 - Rupatadine is effective and safe in the treatment of Chronic Spontaneous Urticaria (CSU) in pediatric patients (2-11 years old)
por: Potter, Paul, et al.
Publicado: (2014)

Suppression of Basophil FcεRI Activation by Serum from Active Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU) Subjects
por: Sterba, Patricia M, et al.
Publicado: (2015)

Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence
por: Metz, Martin, et al.
Publicado: (2020)

Position statement for the use of omalizumab in the management of chronic spontaneous urticaria in Indian patients
por: Godse, Kiran, et al.
Publicado: (2016)

Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Common Variable Immunodeficiency
por: Comberiati, Pasquale, et al.
Publicado: (2019)

Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria
por: Graham, Jonathan, et al.
Publicado: (2016)

Improving of psychological status and inflammatory biomarkers during omalizumab for chronic spontaneous urticaria
por: Diluvio, Laura, et al.
Publicado: (2020)

Response of FcεRI‐bearing leucocytes to omalizumab in chronic spontaneous urticaria
por: Alizadeh Aghdam, Mehran, et al.
Publicado: (2020)

Exploring Machine Learning Techniques to Predict the Response to Omalizumab in Chronic Spontaneous Urticaria
por: Sardina, Davide Stefano, et al.
Publicado: (2021)

Omalizumab Reduces Unplanned Healthcare Interactions in Irish Patients With Chronic Spontaneous Urticaria
por: Ridge, Katie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hju49rim60krdogh627150l9qs